Literature DB >> 18181910

A real-time three-dimensional echocardiographic validation of an intracardiac electrogram-based method for optimizing cardiac resynchronization therapy.

Maria Cristina Porciani1, Carmelo Massimiliano Rao, Matteo Mochi, Francesco Cappelli, Gabriella Bongiorno, Alessandro Paoletti Perini, Alessio Lilli, Giuseppe Ricciardi, Lawrence Hashtroudi, Paolo Silvestri, S Serge Barold, Luigi Padeletti.   

Abstract

INTRODUCTION: Although optimization of atrioventricular and interventricular delays has been demonstrated to improve hemodynamics in patients with cardiac resynchronization therapy (CRT), the required time-consuming procedure discourages its use in clinical practice. Recently, a new method for CRT optimization based on the intracardiac electrogram (IEGM) detected by the implanted leads, has been developed. We evaluated the effectiveness of this method in improving left ventricular (LV) asynchrony and performance using real-time 3D echocardiography (RT3DE). METHODS AND
RESULTS: Twenty patients with CRT were prospectively studied. RT3DE was performed before and after IEGM optimization. The standard deviation of the time to the regional LV minimum systolic volume (Tmsv) for all 16 segments (Tmsv 16-SD), six basal and six mid segments (Tmsv 12-SD), and the six basal segments (Tmsv 6-SD) were assessed as a asynchrony indexes. LV end-diastolic and end-systolic volumes (EDV, ESV), stroke volume (SV), ejection fraction (EF), myocardial performance index (MPI), ejection time (ET), and filling time (FT), corrected by R-R interval, were also evaluated. After IEGM optimization, as compared with baseline Tmsv 12-SD and Tmsv 16-SD decreased (P = 0.01, P< 0.001, respectively), EF and SV improved (P < 0.001, P = 0.01 respectively), FT/RR and ET/RR increased (P = 0.02 for both), and MPI improved (P < 0.001). Tmsv 6-SD, EDV and ESV did not change.
CONCLUSION: A simple IEGM-based method of CRT optimization decreased LV dyssynchrony and improved systolic function.

Entities:  

Mesh:

Year:  2008        PMID: 18181910     DOI: 10.1111/j.1540-8159.2007.00925.x

Source DB:  PubMed          Journal:  Pacing Clin Electrophysiol        ISSN: 0147-8389            Impact factor:   1.976


  7 in total

1.  Echocardiography versus intracardiac electrocardiography-based optimization for cardiac resynchronization therapy : a comparative clinical long-term trial.

Authors:  C J Jensen; A Liadski; M Bell; C K Naber; O Bruder; G V Sabin; B Küpper; H Wieneke
Journal:  Herz       Date:  2011-10       Impact factor: 1.443

Review 2.  Cardiac resynchronization therapy: Dire need for targeted left ventricular lead placement and optimal device programming.

Authors:  Sokratis Pastromas; Antonis S Manolis
Journal:  World J Cardiol       Date:  2014-12-26

Review 3.  Strategies for pacemaker programming in acute heart failure.

Authors:  Marc K Lahiri; Justin T Mao; Claudio D Schuger
Journal:  Heart Fail Rev       Date:  2011-09       Impact factor: 4.214

4.  Impact of moderate exercise workload on predicted optimal AV and VV delays determined by an intracardiac electrogram-based method for optimizing cardiac resynchronization therapy.

Authors:  Margit Strauss; Torsten Becker; Thomas Kleemann; Ngoc Dyck; Frank Birkenhauer; Karlheinz Seidl
Journal:  Clin Res Cardiol       Date:  2010-06-02       Impact factor: 5.460

Review 5.  An Overview of Current Cardiac Resynchronization Therapy.

Authors:  Chien-Ming Cheng; Jin-Long Huang; Tsu-Juey Wu; Yu-Cheng Hsieh; Kuo-Yang Wang; Shih-Ann Chen
Journal:  Acta Cardiol Sin       Date:  2013-11       Impact factor: 2.672

6.  Inadvertent QRS prolongation by an optimization device-based algorithm in patients with cardiac resynchronization therapy.

Authors:  Kamil Sedláček; Rostislav Polášek; Helena Jansová; Domenico Grieco; Pavel Kučera; Josef Kautzner; Darrel P Francis; Dan Wichterle
Journal:  PLoS One       Date:  2022-09-26       Impact factor: 3.752

7.  Cardiac resynchronization therapy during rest and exercise: comparison of two optimization methods.

Authors:  Cinzia Valzania; Maria J Eriksson; Giuseppe Boriani; Fredrik Gadler
Journal:  Europace       Date:  2008-08-27       Impact factor: 5.214

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.